Neuros Medical and VHSS Team Up for Groundbreaking Amputation Pain Treatment for Veterans

Introduction


In a significant move for veterans’ healthcare, Neuros Medical, Inc. has formed an exclusive partnership with Veterans Healthcare Supply Solutions (VHSS). This collaboration aims to introduce the Altius® Direct Electrical Nerve Stimulation System, a state-of-the-art treatment targeting chronic pain among individuals who have undergone amputations. This innovative technology will be available in various VA Healthcare and military treatment facilities throughout the country.

The Importance of Addressing Post-Amputation Pain


Post-amputation pain, which includes phantom limb sensations and pain in the residual limb, affects a substantial proportion of amputees—up to 80% of those impacted. Current treatment options are often inadequate, primarily relying on opioids and other pain medications, which may lead to addiction and other complications. Neuros Medical's introduction of the Altius® System is a crucial step toward addressing this critical healthcare gap.

What is the Altius® Direct Electrical Nerve Stimulation System?


The Altius® System includes a nerve cuff that encircles an affected nerve and an implantable pulse generator (IPG). It represents a patient-controlled, on-demand system that utilizes Neuros' patented technology to disrupt the transmission of pain signals from peripheral nerves, thus alleviating the sensation of pain. With user-initiated treatment sessions lasting 30 minutes, patients can effectively manage their pain as needed.

This technology is FDA-approved, specifically indicated for managing chronic and intractable pain following lower limb amputations in adults. Such advancements provide new hope to many veterans and active-duty military personnel grappling with the physical and emotional consequences of limb loss.

A Commitment to Veterans


David Veino, President and CEO of Neuros Medical, expressed the company’s dedication to improving the quality of life for those who have sacrificed for their country. He stated, “This partnership is an honor. We are truly thankful for the bravery displayed by our veterans, and we aim to offer this groundbreaking treatment as a testament to our gratitude.”

Ryan Hurt, CEO of VHSS, echoed this sentiment, showcasing their mission to introduce effective treatments and technologies to face clinical challenges for federal healthcare customers, specifically honoring the veteran population.

The Future of Pain Management for Amputees


The collaboration between Neuros Medical and VHSS is particularly timely, given the growing population of amputees in the U.S. Today, there are nearly 2 million lower limb amputees, with approximately 300,000 amputations occurring annually. The expectation is that the Altius® System will not only revolutionize pain management in this demographic but will also set a standard for future medical innovations in treating similar ailments.

In conclusion, this partnership marks a transformative chapter for veterans facing the daunting challenge of chronic pain post-amputation. As healthcare continues to evolve, technologies like the Altius® System stand to change lives and restore dignity for those who have bravely served in defense of their nation.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.